ClinicalTrials.gg
Drug

Nimotuzumab clinical trials

studies test it
134
open now
44
in phase 3
27
first study started
2002

How each study uses nimotuzumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the nimotuzumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nimotuzumab
99
h-R3
10
Taixinsheng
9
Nimotuzumab Injection
6
Nimotuzumab and chemotherapy
3

Development codes

Theraloc
1
DE-766
1

Studies by the year they started

134 studies that test it; most in 2009 (13)

Studies that test nimotuzumab, by start year
YearStudies
20021
20051
20074
20083
200913
20104
20118
20125
20137
20145
201510
20163
20173
20185
20193
20207
20219
20227
20237
202410
20259
202610

Who runs them

Industry 13 · Other 121

Biotech Pharmaceutical Co., Ltd. (20) · Sun Yat-sen University (10) · Peking University (7) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (6) · Chinese Academy of Medical Sciences (6) · Tianjin Medical University Cancer Institute and Hospital (6) · Fudan University (5) · YM BioSciences (5)

Often tested with

Tested in the same studies.

Cisplatin (5) · Sintilimab (4) · Irinotecan (3) · Camrelizumab (3) · Toripalimab (3) · Gemcitabine (3) · Tegafur (2) · Gimeracil (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 14, 1 in phase 3

Studies that test nimotuzumab, phase 3 first.

Studies

Open first, then newest update. How each study uses nimotuzumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 134

See all 134 studies that test nimotuzumab →

Given beside what is tested · 6 — nimotuzumab is usual care or a partner of the new treatment

Codes

What other systems call nimotuzumab · ClinicalTrials.gg INT004790

  • MeSH (NLM) C501466nimotuzumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6NS400BXKHNIMOTUZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q3877039nimotuzumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2733NimotuzumabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.